-
Je něco špatně v tomto záznamu ?
Screening of the Medicines for Malaria Venture Pandemic Response Box for Discovery of Antivirulent Drug against Pseudomonas aeruginosa
M. Macho, S. Saha, G. Konert, A. Banerjee, D. Ewe, P. Hrouzek, P. Urajová, K. Saurav
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2021
Freely Accessible Science Journals
od 2013 do Před 2 roky
PubMed Central
od 2017
ROAD: Directory of Open Access Scholarly Resources
od 2013
- MeSH
- antibakteriální látky farmakologie metabolismus MeSH
- biofilmy * MeSH
- faktory virulence metabolismus MeSH
- pandemie MeSH
- Pseudomonas aeruginosa * MeSH
- quorum sensing MeSH
- Publikační typ
- časopisecké články MeSH
Resistance development and exhaustion of the arsenal of existing antibacterial agents urgently require an alternative approach toward drug discovery. Herein, we report the screening of Medicines for Malaria Venture (MMV) Pandemic Response Box (PRB) through a cascade developed to streamline the potential compounds with antivirulent properties to combat an opportunistic pathogen, Pseudomonas aeruginosa. To find an agent suppressing the production of P. aeruginosa virulence factors, we assessed the potential of the compounds in PRB with quorum sensing inhibitory activity. Our approach led us to identify four compounds with significant inhibition of extracellular virulence factor production and biofilm formation. This provides an opportunity to expand and redirect the application of these data sets toward the development of a drug with unexplored target-based activity. IMPORTANCE The rise of drug-resistant pathogens as well as overuse and misuse of antibiotics threatens modern medicine as the number of effective antimicrobial drugs steadily decreases. Given the nature of antimicrobial resistance development under intense selective pressure such as the one posed by pathogen-eliminating antibiotics, new treatment options which could slow down the emergence of resistance are urgently needed. Antivirulence therapy aims at suppressing a pathogen's ability to cause disease rather than eliminating it, generating significantly lower selective pressure. Quorum sensing inhibitors are thought to be able to downregulate the production of virulence factors, allowing for smaller amounts of antimicrobials to be used and thus preventing the emergence of resistance. The PRB constitutes an unprecedented opportunity to repurpose new as well as known compounds with cytotoxicity and in vitro absorption, distribution, metabolism and excretion (ADME) profile available, thus shortening the time between compound discovery and medicinal use.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032118
- 003
- CZ-PrNML
- 005
- 20230131151812.0
- 007
- ta
- 008
- 230120s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/spectrum.02232-22 $2 doi
- 035 __
- $a (PubMed)36301146
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Macho, Markéta $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic $u University of South Bohemia, Faculty of Science, České Budějovice, Czech Republic
- 245 10
- $a Screening of the Medicines for Malaria Venture Pandemic Response Box for Discovery of Antivirulent Drug against Pseudomonas aeruginosa / $c M. Macho, S. Saha, G. Konert, A. Banerjee, D. Ewe, P. Hrouzek, P. Urajová, K. Saurav
- 520 9_
- $a Resistance development and exhaustion of the arsenal of existing antibacterial agents urgently require an alternative approach toward drug discovery. Herein, we report the screening of Medicines for Malaria Venture (MMV) Pandemic Response Box (PRB) through a cascade developed to streamline the potential compounds with antivirulent properties to combat an opportunistic pathogen, Pseudomonas aeruginosa. To find an agent suppressing the production of P. aeruginosa virulence factors, we assessed the potential of the compounds in PRB with quorum sensing inhibitory activity. Our approach led us to identify four compounds with significant inhibition of extracellular virulence factor production and biofilm formation. This provides an opportunity to expand and redirect the application of these data sets toward the development of a drug with unexplored target-based activity. IMPORTANCE The rise of drug-resistant pathogens as well as overuse and misuse of antibiotics threatens modern medicine as the number of effective antimicrobial drugs steadily decreases. Given the nature of antimicrobial resistance development under intense selective pressure such as the one posed by pathogen-eliminating antibiotics, new treatment options which could slow down the emergence of resistance are urgently needed. Antivirulence therapy aims at suppressing a pathogen's ability to cause disease rather than eliminating it, generating significantly lower selective pressure. Quorum sensing inhibitors are thought to be able to downregulate the production of virulence factors, allowing for smaller amounts of antimicrobials to be used and thus preventing the emergence of resistance. The PRB constitutes an unprecedented opportunity to repurpose new as well as known compounds with cytotoxicity and in vitro absorption, distribution, metabolism and excretion (ADME) profile available, thus shortening the time between compound discovery and medicinal use.
- 650 12
- $a Pseudomonas aeruginosa $7 D011550
- 650 12
- $a biofilmy $7 D018441
- 650 _2
- $a pandemie $7 D058873
- 650 _2
- $a antibakteriální látky $x farmakologie $x metabolismus $7 D000900
- 650 _2
- $a quorum sensing $7 D053038
- 650 _2
- $a faktory virulence $x metabolismus $7 D037521
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Saha, Subhasish $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic
- 700 1_
- $a Konert, Grzegorz $u Laboratory of Photosynthesis, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic
- 700 1_
- $a Banerjee, Avik $u Laboratory of Photosynthesis, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic
- 700 1_
- $a Ewe, Daniela $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic
- 700 1_
- $a Hrouzek, Pavel $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic $1 https://orcid.org/0000000220610266
- 700 1_
- $a Urajová, Petra $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic
- 700 1_
- $a Saurav, Kumar $u Laboratory of Algal Biotechnology, Institute of Microbiology of the Czech Academy of Sciences-Center Algatech, Třeboň, Czech Republic $1 https://orcid.org/0000000270844204
- 773 0_
- $w MED00209157 $t Microbiology spectrum $x 2165-0497 $g Roč. 10, č. 6 (2022), s. e0223222
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36301146 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151808 $b ABA008
- 999 __
- $a ok $b bmc $g 1891100 $s 1183453
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 10 $c 6 $d e0223222 $e 20221027 $i 2165-0497 $m Microbiology spectrum $n Microbiol Spectr $x MED00209157
- LZP __
- $a Pubmed-20230120